Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Expression of Bmi-1 protein in tumor tissues is associated with favorable prognosis in breast cancer patients.

Breast cancer research and treatment - 1 Jan 2009

Choi Young Jin, Choi Yoon La, Cho Eun Yoon, Shin Young Kee, Sung Ki Woong, Hwang Yu Kyeong, Lee Sang Jin, Kong Gu, Lee Jeong Eon, Kim Jee Soo, Kim Jung Han, Yang Jung-Hyun, Nam Seok Jin

Abstract excerpt

PURPOSE: Abnormal expression of the cell cycle regulatory protein Bmi-1 has been studied in breast cancer, but the clinical relevance has not been fully elucidated. We studied the expression of Bmi-1 protein in breast cancer patients to define its clinical significance in breast cancer. EXPERIMENTAL DESIGN: Tissue microarrays were performed to evaluate the expression of Bmi-1 by immunohistochemistry in tumor...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cell Cycle
Share to Neoplasm Staging

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Nuclear Proteins

Share to Oligonucleotide Array Sequence Analysis

Share to Polycomb Repressive Complex 1

Share to Proto-Oncogene Proteins

Share to Repressor Proteins

Share to RNA, Neoplasm

Source

Identifiers

PMID: 18228133
DOI: 10.1007/s10549-008-9909-4

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Expression of Bmi-1 protein in tumor tissues is associated with favorable prognosis in breast cancer patients.PMID 18228133Read ↗

BMI ‐1 promotes breast cancer proliferation and metastasis through different mechanisms in different subtypesSemantic proximity Read ↗

BMI1: A Biomarker of Hematologic MalignanciesSemantic proximity Read ↗

BMI1 as a novel target for drug discovery in cancerSemantic proximity Read ↗

BMI-1, a promising therapeutic target for human cancerSemantic proximity Read ↗

Cancer stem cell marker Bmi-1 expression is associated with basal-like phenotype and poor survival in breast cancer.Semantic proximity Read ↗

Ewing tumors that do not overexpress BMI-1 are a distinct molecular subclass with variant biology: a report from the Children's Oncology Group.Semantic proximity Read ↗

Low BMI-1 expression is associated with an activated BMI-1-driven signature, vascular invasion, and hormone receptor loss in endometrial carcinoma.Semantic proximity Read ↗

Overexpression of BMI-1 Promotes Cell Growth and Resistance to Cisplatin Treatment in OsteosarcomaSemantic proximity Read ↗

Breast cancer metastasis suppressor gene, breast cancer metastasis suppressor 1, may be associated with clinicopathological features of breast cancer.Semantic proximity Read ↗

Bmi-1 induces radioresistance in MCF-7 mammary carcinoma cellsSemantic proximity Read ↗

Expression of the polycomb-group gene BMI1 is related to an unfavourable prognosis in primary nodal DLBCLSemantic proximity Read ↗

<i>Bmi‐1</i> gene is upregulated in early‐stage hepatocellular carcinoma and correlates with ATP‐binding cassette transporter B1 expressionSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.